Company intelligence / Profile preview

Polso

Ownership: Private
Development stage: Commercial

Overview

Polso™, developed by ChroniSense Medical, is an FDA-cleared remote patient monitoring solution that combines a medical-grade wrist-worn device with a mobile app and cloud-based clinician dashboard. It enables continuous vital sign tracking—including blood oxygen saturation, respiration rate, pulse rate—with additional parameters like blood pressure in development. Clinical validation studies have demonstrated accuracy and ease of use across diverse populations. The system supports both routine chronic care management and decentralized clinical trials[2][7].

Therapeutic areas: OtherCardiovascular
Modalities: DeviceDigital health platformRemote patient monitoring technology
Industry: Physiological Monitoring

Partnerships

Collaborations with leading hospitals and expert practitioners in the U.S. and globally; specific names not disclosed

Beyond the preview

Go deeper on Polso.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polso.

Explore the full profile